BCAAs, particularly leucine, activates the mammalian target of mTORC1, the key intersection of amino acid and insulin signaling pathways, but chronic activation can inhibit the insulin receptor pathway and reduce insulin sensitivity, promoting the development of insulin resistance, obesity, and type 2 diabetes [92,93]. The gene discussed is INS; the disease is type 2 diabetes mellitus.